A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)

Stopped early · Phase 1/Phase 2

Conditions studied: Vitreoretinal Traction Syndrome

In brief

Plasmin is expected to create a posterior vitreous detachment (PVD) when injected directly into the eye. The pharmacological creation of a PVD may be beneficial in helping to treat a variety of conditions.

Key facts

Study ID

NCT00347646

Run by

Bausch & Lomb Incorporated

People needed

4

Starts

2006-09-01

Expected to finish

2007-06-01

Last updated by the study team

2019-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are in need of a vitrectomy.

You may not qualify if…

• A PVD in the study eye as assessed by the investigator using ophthalmic and alternative examination techniques.
• A history of vitrectomy in the study eye.
• A media opacity that precludes quality examination of the vitreous and fundus in the study eye.

Where it is running

• University Hospitals of Cleveland — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.